Amgen to Acquire Horizon Therapeutics for US$28.3 B

By Lucy Haggerty

Pharma Deals Review: Vol 2022 Issue 12 (Table of Contents)

Published: 19 Dec-2022

DOI: 10.3833/pdr.v2022.i12.2754     ISSN: 1756-7874

Section: Mergers & Acquisitions



In an attempt to address its upcoming revenue gap, Amgen has agreed to acquire Horizon Therapeutics for US$116...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details